Cargando…
Human Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Cerebellar Ataxia: A Case Report
To date, there is no curable treatment option for non-hereditary degenerative cerebellar ataxia. Here we report the case of a patient with sporadic adult-onset ataxia (SAOA) who underwent allogeneic bone marrow-derived mesenchymal stem cell (MSC) therapy via the intrathecal route. A 60-year-old male...
Autores principales: | Ko, Pan-Woo, Park, Sangmin, Kang, Kyunghun, Lim, Yong-Hyun, Kim, Sang Ryong, Suk, Kyoungho, Kim, Kyung Suk, Lee, Ho-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067136/ https://www.ncbi.nlm.nih.gov/pubmed/33915966 http://dx.doi.org/10.3390/medicina57040334 |
Ejemplares similares
-
Therapeutic Effects of Human Mesenchymal Stem Cells in a Mouse Model of Cerebellar Ataxia with Neuroinflammation
por: Nam, Youngpyo, et al.
Publicado: (2020) -
Lipopolysaccharide administration for a mouse model of cerebellar ataxia with neuroinflammation
por: Hong, Jungwan, et al.
Publicado: (2020) -
Characterization of Mesenchymal Stem Cells Derived from Patients with Cerebellar Ataxia: Downregulation of the Anti-Inflammatory Secretome Profile
por: Kim, Jong-Heon, et al.
Publicado: (2020) -
Mesenchymal Stem Cell Transplantation Ameliorates Ara-C-Induced Motor Deficits in a Mouse Model of Cerebellar Ataxia
por: Park, Narae, et al.
Publicado: (2023) -
Tonsil-derived mesenchymal stem cells enhance allogeneic bone marrow engraftment via collagen IV degradation
por: Lee, Hyun-Ji, et al.
Publicado: (2021)